Bennett, C. L., Hoque, S., Olivieri, N., Taylor, M. A., Aboulafia, D., Lubaczewski, C., . . . Smith, W. K. (2021). Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR). EClinicalMedicine, 31, . https://doi.org/10.1016/j.eclinm.2020.100693

Bennett, Charles L., et al. "Consequences to Patients, Clinicians, and Manufacturers When Very Serious Adverse Drug Reactions Are Identified (1997–2019): A Qualitative Analysis from the Southern Network on Adverse Reactions (SONAR)." EClinicalMedicine 31 (2021). https://doi.org/10.1016/j.eclinm.2020.100693.

Bennett, Charles L., et al. "Consequences to Patients, Clinicians, and Manufacturers When Very Serious Adverse Drug Reactions Are Identified (1997–2019): A Qualitative Analysis from the Southern Network on Adverse Reactions (SONAR)." EClinicalMedicine, vol. 31, 2021, https://doi.org/10.1016/j.eclinm.2020.100693.